Safety and Efficacy of OPN Balloon in Patients With Calcified Coronary Artery Disease

被引:5
|
作者
Senguttuvan, Nagendra Boopathy [1 ,4 ]
Singh, Harsimran [1 ]
Kumar, Balakrishnan Vinod [1 ]
Kongara, Rahul Chowdary [1 ]
Abdulkader, Rizwan Suliankatchi [2 ]
Anandaram, Asuwin [3 ]
Krishnamurthy, Preetam [1 ]
Balasubramaniyan, Jayanthy Venkata [1 ]
Sadhanandham, Shanmugasundram [1 ]
Ramesh, Sankaran [1 ]
Manokar, Panchanatham [1 ]
Muralidharan, Thoddi Ramamurthy [1 ]
Murthy, Jayanthy S. N. [1 ]
Thanikachalam, Sadagopan [1 ]
机构
[1] Sri Ramachandra Inst Higher Educ & Res SRIHER, Dept Cardiol, 1 Ramachandra Nagar,Porur, Chennai 600116, Tamil Nadu, India
[2] Natl Inst Epidemiol, ICMR, Scientist D, Chennai, India
[3] Sri Ramachandra Inst Higher Educ & Res SRIHER, Dept Clin Res, 1,Ramachandra Nagar,Porur, Chennai 600116, Tamil Nadu, India
[4] SRIHER, Dept Cardiol, Chennai, India
关键词
OPN balloon; Calcified lesions; Stent expansion; CAD; SIROLIMUS-ELUTING STENTS; LESIONS;
D O I
10.1016/j.carrev.2023.02.018
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Patients with symptomatic calcified coronary lesions have poor outcomes. Such lesions require additional atherectomy devices for bed preparation. Aim: To assess the safety and efficacy of OPN balloon in patients with calcified coronary lesions.Methods: This is an investigator-initiated, prospective, observational study. The primary outcome of the study was a procedural success.Results: We studied 71 patients (133 lesions). Maximum lesions were located in LAD [46.6 %]. The OPN balloon was used for pre-dilatation alone in 28.6 % (Pre-stent OPN group), post-dilatation alone in 63.2 % of lesions (Post-stent OPN group), and in both situations in 8.3 % of lesions with procedural success in 98.5 % of patients. Further dilatation with different NC balloons was required in both groups (30 %). The median (IQR) OPN balloon diameter in the pre-and post-stent OPN group were 2.5 (2.5, 3.0) and 3.0 (3.0,3.0) mm (p = 0.001), respectively. The difference between the diameter of the stent and OPN balloon used in pre-stent OPN group was 0.5 (0.2, 0.5) mm while it was 0.0 (0.0,0.2) mm in the post-stent OPN group (p < 0.001). Eight complications and two deaths occured. Distal shaft rupture was also noticed. Conclusion: OPN balloon is safe, and effective in treating calcified coronary lesions. We propose to undersize the balloon by 0.5 mm for pre-dilatation followed by 0.25 mm larger NC balloon if needed. In the post-dilatation group, use a 1:1 size balloon in a non-tortuous straight segment. Use imaging especially when (1) the pressure taken more than the rated burst pressure, (2) an OPN balloon size is >= 3 mm (3) using 1:1 size OPN balloon in a tortuous segment.(c) 2023 Elsevier Inc. All rights reserved.
引用
收藏
页码:25 / 30
页数:6
相关论文
共 50 条
  • [21] Efficacy and safety of switching simvastatin intolerant patients with coronary artery disease to rosuvastatin treatment
    Shek, A. B.
    Kurbanov, R. D.
    Abdullaeva, G. J.
    Nagay, A. V.
    Hoshimov, S. U.
    Nizamov, U. I.
    EUROPEAN HEART JOURNAL, 2017, 38 : 160 - 160
  • [22] Efficacy of Multichannel Balloon Angioplasty in Calcified Common Femoral Artery Lesions
    Nagatomi, Satoru
    Ichihashi, Shigeo
    Yamamoto, Hiroshi
    Iwakoshi, Shinichi
    Taguchi, Hidehiko
    Inagaki, Masahiro
    Yoshiyama, Yutaka
    Nakai, Takahiro
    Shimohara, Yuichi
    Bolstad, Francesco
    Kichikawa, Kimihiko
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2021, 32 (02) : 181 - 186
  • [23] EFFICACY AND SAFETY OF ROSUVASTATIN COMPARED TO SIMVASTSTIN IN CORONARY ARTERY DISEASE
    Khan, Shimal
    Abrar, Amjad
    Rafique, Ahmad
    Abid, Abdul Rehman
    Jan, Tehmina
    GOMAL JOURNAL OF MEDICAL SCIENCES, 2010, 8 (01): : 64 - 69
  • [24] Rotablation and coronary aneurism in severe calcified coronary artery disease
    Barbieri, Lucia
    Tumminello, Gabriele
    Lucreziotti, Stefano
    Rametta, Francesco
    Carugo, Stefano
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0J) : J89 - J90
  • [26] Safety and Efficacy of an Innovative Everolimus-Coated Balloon in a Swine Coronary Artery Model
    Katsouras, Christos S.
    Tousis, Alexandros
    Vasilagkos, Georgios
    Semertzioglou, Arsen
    Vratimos, Athanassios
    Samara, Ioanna
    Karanasiou, Georgia
    Loukas, Vasileios S.
    Tsigkas, Grigorios
    Fotiadis, Dimitrios
    Michalis, Lampros K.
    Davlouros, Periklis
    Moulas, Anargyros N.
    LIFE-BASEL, 2023, 13 (10):
  • [27] Efficacy and Safety of Intravascular Lithotripsy Versus Rotational Atherectomy in Balloon-Crossable Heavily Calcified Coronary Lesions
    Mousa, Mohamed A. A.
    Bingen, Brian O.
    Al Amri, Ibtihal
    Mertens, B. J. A.
    Taha, Salma
    Tohamy, Aly
    Youssef, Amr
    Jukema, J. Wouter
    Montero-Cabezas, Jose M.
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2023, 48 : 1 - 6
  • [28] Incidence and prognostic impact of the calcified nodule in coronary artery disease patients on hemodialysis
    Okamura, Akihiko
    Okura, Hiroyuki
    Kyodo, Atsushi
    Iwai, Saki
    Keshi, Ayaka
    Kanaoka, Koshiro
    Kyodo, Atsushi
    Sakagami, Azusa
    Kamon, Daisuke
    Hashimoto, Yukihiro
    Hashimoto, Yukihiro
    Ueda, Tomoya
    Soeda, Tsunenari
    Watanabe, Makoto
    Saito, Yoshihiko
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (13) : B170 - B171
  • [29] Impact of serum cholinesterase on calcified nodules in patients with stable coronary artery disease
    Kanda, Daisuke
    Tokushige, Akihiro
    Ohmure, Kenta
    Shimono, Hirokazu
    Tabata, Hiroyuki
    Ito, Nobuhiro
    Kubozono, Takuro
    Ohishi, Mitsuru
    CORONARY ARTERY DISEASE, 2025, 36 (01) : 70 - 77
  • [30] Efficacy and safety of coronary computed tomography angiography in patients with a high clinical likelihood of obstructive coronary artery disease
    Rudzinski, Piotr N.
    Kruk, Mariusz
    Demkow, Marcin
    Oleksiak, Anna
    Schoepf, Joseph U.
    Mach, Markus
    Dzielinska, Zofia
    Pregowski, Jerzy
    Witkowski, Adam
    Ruzyllo, Witold
    Kepka, Cezary
    KARDIOLOGIA POLSKA, 2022, 80 (01) : 57 - 63